Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment

被引：0

作者：

Kostikas, Konstantinos

Loefroth, Emil ^{[1
]}

Kottakis, Ioannis ^{[2
]}

Mcgettigan, Paul ^{[3
]}

Mcsharry, Martin ^{[3
]}

Cao, Hui ^{[4
]}

机构：

[1] Novartis Sverige AB, Kista, Sweden

[2] Novartis Pharma AG, Basel, Switzerland

[3] Novartis Ireland Ltd, Dublin, Ireland

[4] Novartis Pharmaceut, E Hanover, NJ USA

来源：

关键词：

Asthma; -; management; Smoking; Exacerbation;

D O I：

10.1183/13993003.congress-2019.PA3711

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

PA3711

引用

页数：2